Benchmark 2018-B1 Mortgage Trust has released its monthly distribution report for October 2026, revealing significant information regarding its asset performance. The report indicates an increase in delinquencies and losses among the trust's commercial mortgage assets, which could have implications for investors and the broader asset-backed securities market.
As of October 30, 2026, the trust reported that a distribution was made to holders of its certificates on October 19, 2026. This marks an important update for stakeholders as it reflects the trust's ongoing performance in a challenging economic environment.
Background
Benchmark 2018-B1 Mortgage Trust, classified under the SIC code 6189 for Asset-Backed Securities, is an operating entity based in New York. The trust has been actively filing reports with the SEC, including its recent 10-D and ABS-EE forms on October 30, 2026. The trust's filings provide crucial insights into its financial health and operational status.
What the Filing Says
The filing details that on October 19, 2026, a distribution was made to the certificate holders. It also notes, "The distribution report is attached as an Exhibit to this Form 10-D." The report includes loss information for the trust assets, highlighting the number of delinquencies and losses.
Impact
The report indicates that there were five delinquencies of 30 days or more, representing 21.45% of the pool balance. Additionally, three loans or REOs incurred losses, with an average net loss of $8,072,919.87. These figures suggest that the trust is facing challenges that could affect its investors and the overall market for asset-backed securities.
What's Next
The next distribution date is scheduled for November 18, 2026. The filing does not specify any further actions or developments beyond this upcoming distribution.
Read Next
BP Sells 5% Stake in Aker BP for $1.06 Billion
WeRide Inc. Reports Stability in Share Capital Movements
Bullish Releases October 2026 Monthly Metrics Report
Chimera Investment Corp declares cash dividends for Q4 2026
Modern Mining Technology registers common shares on NYSE American
Innate Pharma Reports Q3 2026 Update, Highlights Pipeline Progress










